These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17473064)

  • 21. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
    Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
    Molad Y; Pokroy-Shapira E; Carmon V
    Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulatory type A CpG-DNA induces a Th2-like response in human endothelial cells.
    Fitzner N; Zahner L; Habich C; Kolb-Bachofen V
    Int Immunopharmacol; 2011 Nov; 11(11):1789-95. PubMed ID: 21820085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice.
    Gilibert S; Galle-Treger L; Moreau M; Saint-Charles F; Costa S; Ballaire R; Couvert P; Carrié A; Lesnik P; Huby T
    J Immunol; 2014 Jul; 193(2):817-26. PubMed ID: 24935924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of IRAK-4 is a component of LPS- and CpG DNA-induced tolerance in macrophages.
    De Nardo D; Nguyen T; Hamilton JA; Scholz GM
    Cell Signal; 2009 Feb; 21(2):246-52. PubMed ID: 18992325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.
    Chesnokova V; Auernhammer CJ; Melmed S
    Endocrinology; 1998 May; 139(5):2209-16. PubMed ID: 9564824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals.
    Bornstein SR; Schumann RR; Rettori V; McCann SM; Zacharowski K
    Horm Metab Res; 2004 Jul; 36(7):470-3. PubMed ID: 15305230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
    Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
    Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.
    Qiao B; Li B; Yang X; Zhang H; Chu Y; Wang Y; Xiong S
    Cell Mol Immunol; 2005 Apr; 2(2):130-5. PubMed ID: 16191419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4.
    Kato S; Yuzawa Y; Tsuboi N; Maruyama S; Morita Y; Matsuguchi T; Matsuo S
    J Am Soc Nephrol; 2004 May; 15(5):1289-99. PubMed ID: 15100369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model.
    Kim SC; Wu S; Fang X; Neumann J; Eichhorn L; Schleifer G; Boehm O; Meyer R; Frede S; Hoeft A; Baumgarten G; Knuefermann P
    Life Sci; 2014 Dec; 119(1-2):1-8. PubMed ID: 25445440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.
    Ruan M; Thorn K; Liu S; Li S; Yang W; Zhang C; Zhang C
    Int J Oncol; 2014 Jun; 44(6):2103-10. PubMed ID: 24676671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
    Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
    J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propolis effects on pro-inflammatory cytokine production and Toll-like receptor 2 and 4 expression in stressed mice.
    Pagliarone AC; Orsatti CL; Búfalo MC; Missima F; Bachiega TF; Júnior JP; Sforcin JM
    Int Immunopharmacol; 2009 Oct; 9(11):1352-6. PubMed ID: 19699326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.